Allergan Triumphs In 'Botox' Trademark Dispute

Law360, New York (November 5, 2013, 6:27 PM EST) -- The Trademark Trial and Appeals Board has found that Allergan Inc.'s “Botox” name is a famous trademark and that another company couldn't register the word “Botulex” for marketing a no-injection alternative to the cosmetic treatment.

The TTAB said Allergan had spent more than $10 billion in advertising the name over the past 14 years and that within the target demographic — high-income women between ages 30 and 60 — a whopping 95 percent knew what Botox was.

The board noted that KRL Group Inc. wanted to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.